“It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty,” a spokesman added, saying it would depend on animal trials as to whether it could be considered “a promising candidate research vaccine” for Bundibugyo.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

NHS needs better plan around weight loss jabs, warn experts

An urgent review is needed to make sure people in England can get weight loss jabs such as Wegovy and Mounjaro on the NHS, top experts warn. It comes a

CAR-T cells hold memories of past encounters

Researchers at the University of Colorado Anschutz Medical Campus have discovered that some CAR-T cells engineered to fight cancer and other conditions carry the memory of past encounters with bacteria,

The man who wants to bring human composting to the UK

Human composting is when a body placed in a sealed vessel containing organic matter turns into soil. Source link